Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy

Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-  Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence

(2016) B. Kisacik et al.   JOURNAL OF RHEUMATOLOGY

Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research

(2016) Hye Won Kim et al.   PLoS One

Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom

(2015) Muhammad K. Nisar et al.   CLINICAL RHEUMATOLOGY

Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-α Treatment

(2015) Sermin Borekci et al.   RESPIRATION

Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy

(2014) Young Sun Suh et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors

(2014) Y. J. Kim et al.   RHEUMATOLOGY

Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment

(2010) B. Denis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada

(2009) Paul Brassard et al.   ARTHRITIS AND RHEUMATISM

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry

(2009) F. Tubach et al.   ARTHRITIS AND RHEUMATISM